0001235802-24-000050.txt : 20240603 0001235802-24-000050.hdr.sgml : 20240603 20240603164113 ACCESSION NUMBER: 0001235802-24-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240601 FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pauls Dietrich John CENTRAL INDEX KEY: 0001760123 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36291 FILM NUMBER: 241014333 MAIL ADDRESS: STREET 1: 2 CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc. CENTRAL INDEX KEY: 0001401040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 BUSINESS PHONE: (763) 496-5454 MAIL ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 FORMER COMPANY: FORMER CONFORMED NAME: DiaMedica Inc. DATE OF NAME CHANGE: 20070525 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2024-06-01 0 0001401040 DiaMedica Therapeutics Inc. DMAC 0001760123 Pauls Dietrich John 301 CARLSON PARKWAY, SUITE 210 MINNEAPOLIS MN 55305 1 1 0 0 President and CEO 0 Voting Common Shares, no par value per share 68591 D Stock Option (right to buy) 2.9 2024-06-01 4 A 0 300000 0 A 2034-05-31 Common Shares 300000 300000 D Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan. Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025. /s/ Amy E. Culbert, attorney-in-fact 2024-06-03